BPC-157 and Cancer Risk Although we see claims saying that BPC157, a peptide, can increase the risk of cancer, there is no scientific evidence suggesting this
The short answer is they are not competing options
Watch for: MOTS-C: mild energy changes weeks 12, more noticeable improvement by week 34 5-Amino-1MQ: subtle metabolic shift, most noticeable when combined with consistent Zone 2 cardio NAD+: gradual energy improvement, not stimulant-like Timing: Reta: once weekly subQ MOTS-C: 500mcg/day subQ, morning fasted or pre-workout NAD+ (NMN/NR): morning with food 5-Amino-1MQ: morning, fasted or with NAD+ supplement What to Realistically Expect 5-Amino-1MQ is not a dramatic compound
The initial retinization period typically lasts from two to six weeks, though it can vary
In recent years, certain peptides have gained attention as potential treatments for erectile dysfunction (ED), though their use remains largely experimental and outside mainstream clinical practice in the UK